NEW YORK, NY / ACCESSWIRE / March 7, 2018 / U.S. markets had a topsy-turvy day as concerns of a potential trade war, a result of tariffs proposed by President Donald Trump, continue to worry investors. The Dow Jones Industrial Average hit a low of 24,708.41, before settling to close at 24,884.12, an increase of 0.04 percent, while the S&P 500 Index hit a low of 2,711.26, before settling to close at 2,728.12, an increase of 0.26 percent. Major Indexes fell in Tuesday trading after Bloomberg News reported President Trump believes top economic advisor Gary Cohn could resign due to the new proposed tariffs on imports of steel and aluminum.

RDI Initiates Coverage on:

ImmunoCellular Therapeutics, Ltd.
https://rdinvesting.com/news/?ticker=IMUC

Spectrum Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=SPPI

ImmunoCellular Therapeutics' stock jumped 20.70% Tuesday, to close the day at $0.33. The stock recorded a trading volume of 5,635,641 shares, which was above its three months average volume of 2,825,836 shares. In the last year, ImmunoCellular Therapeutics' shares have traded in a range of 0.17 - 3.60. The share price has gained 94.12% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.26 is below its 200-day moving average of $0.31. Shares of ImmunoCellular Therapeutics have gained roughly 37.5 percent in the past month and are up 4.43 percent year-to-date.

Access RDI's ImmunoCellular Therapeutics, Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=IMUC

On Tuesday, shares of Spectrum Pharmaceuticals recorded a trading volume of 1,428,340 shares, which was above the three months average volume of 1,170,651 shares. The stock ended the day 0.57% lower at 21.09. The share price has gained 285.56% from its 52-week low with a 52-week trading range of 5.47 - 23.50.The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $21.02 is greater than its 200-day moving average of $17.11. Shares of Spectrum Pharmaceuticals have gained roughly 0.48 percent in the past month and are up 11.29 percent year-to-date.

Access RDI's Spectrum Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SPPI

Our Actionable Research on ImmunoCellular Therapeutics, Ltd. (NYSEAMERICAN: IMUC) and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com